2025
SJR Q2
JCR Q2 · 1,8
77 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Child and Adolescent Psychopharmacology
- Yayıncı
- Mary Ann Liebert Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
1044546315578992
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,618
- Quartile Q2
- H-Index 100
- Atıf/yayın 1,41
- Doküman (3y) 207
- Atıf (3y) 335
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 1,8
- 5Y JIF 1,9
- JCI 0,72
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Pediatrics, Perinatology and Child Health Q2
- Pharmacology (medical) Q2
- Psychiatry and Mental Health Q2
Alanlar
- Medicine
WoS kategorileri
- Pediatrics | Pharmacology & Pharmacy | Psychiatry
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,618 | 1,8 | 1,9 | 0,72 | Q2 | 100 |
| 2024 | Q2 | Q2 | 0,619 | 2,2 | 2,2 | 0,63 | Q3 | 95 |
| 2023 | Q2 | Q2 | 0,604 | 1,5 | 3 | 0,54 | Q3 | 95 |
| 2022 | Q1 | Q3 | 0,774 | 1,9 | 2,3 | 0,66 | Q2 | 95 |
| 2021 | Q1 | Q2 | 1,033 | 3 | 3,4 | 0,76 | Q2 | 95 |
| 2020 | Q1 | Q2 | 0,935 | 2,6 | 3 | 0,9 | Q2 | 95 |
| 2019 | Q1 | Q2 | 0,996 | 2,3 | 2,5 | 1 | Q1 | 95 |
| 2018 | — | Q2 | — | 2,2 | 2,4 | 1,08 | Q1 | — |
| 2017 | Q1 | Q1 | 1,316 | 2,9 | 2,8 | 1,11 | Q1 | 95 |
| 2016 | Q1 | Q1 | 0,897 | 2,4 | 2,9 | — | — | 95 |
| 2015 | Q1 | Q2 | 0,932 | 2,1 | 2,9 | — | — | 95 |
| 2014 | Q1 | Q1 | 1,203 | 2,9 | 3,4 | — | — | 95 |
| 2013 | Q1 | Q1 | 1,089 | 3,1 | 3,4 | — | — | 95 |
| 2012 | Q1 | Q1 | 1,219 | 2,8 | 3 | — | — | 95 |
| 2011 | Q1 | Q1 | 1,078 | 2,9 | 2,9 | — | — | 95 |
| 2010 | Q1 | Q1 | 0,911 | 2,5 | 2,7 | — | — | 95 |
| 2009 | — | Q1 | — | 2,6 | 2,9 | — | — | — |
| 2008 | — | Q1 | — | 2,6 | 3 | — | — | — |
| 2007 | — | Q1 | — | 3,1 | 3,4 | — | — | — |
| 2006 | — | Q1 | — | 2,5 | — | — | — | — |
| 2005 | — | Q1 | — | 2,3 | — | — | — | — |
| 2004 | — | Q1 | — | 2,5 | — | — | — | — |
| 2003 | — | Q1 | — | 2,5 | — | — | — | — |
| 2002 | — | Q1 | — | 2,5 | — | — | — | — |
| 2001 | — | Q1 | — | 1,8 | — | — | — | — |
| 2000 | — | Q1 | — | 2 | — | — | — | — |
| 1999 | — | Q1 | — | 2,1 | — | — | — | — |
| 1998 | — | Q1 | — | 1,6 | — | — | — | — |
| 1997 | — | Q1 | — | 1,9 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PEDIATRICS | SCIE | Q2 | Q2 | 90/190 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 258/356 |
| 2025 | PSYCHIATRY | SCIE | Q3 | Q2 | 200/293 |
| 2024 | PEDIATRICS | SCIE | Q2 | Q3 | 57/191 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 209/352 |
| 2024 | PSYCHIATRY | SCIE | Q3 | Q3 | 152/288 |
| 2023 | PEDIATRICS | SCIE | Q2 | Q3 | 86/186 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 265/354 |
| 2023 | PSYCHIATRY | SCIE | Q3 | Q3 | 192/279 |
| 2022 | PEDIATRICS | SCIE | Q3 | Q2 | 74/130 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q2 | 224/278 |
| 2022 | PSYCHIATRY | SCIE | Q4 | Q3 | 129/155 |
| 2021 | PEDIATRICS | SCIE | Q2 | Q2 | 51/130 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 177/279 |
| 2021 | PSYCHIATRY | SCIE | Q3 | Q2 | 104/155 |
| 2020 | PEDIATRICS | SCIE | Q2 | Q2 | 48/129 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 190/276 |
| 2020 | PSYCHIATRY | SCIE | Q3 | Q2 | 105/156 |
| 2019 | PEDIATRICS | SCIE | Q2 | Q1 | 39/128 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 172/271 |
| 2019 | PSYCHIATRY | SCIE | Q3 | Q2 | 86/155 |
| 2018 | PEDIATRICS | SCIE | Q2 | Q1 | 47/125 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q1 | 168/267 |
| 2018 | PSYCHIATRY | SCIE | Q3 | Q1 | 86/146 |
| 2017 | PEDIATRICS | SCIE | Q1 | Q1 | 19/124 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 100/261 |
| 2017 | PSYCHIATRY | SCIE | Q2 | Q1 | 57/142 |
| 2016 | PEDIATRICS | SCIE | Q1 | — | 28/121 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 128/257 |
| 2016 | PSYCHIATRY | SCIE | Q2 | — | 67/142 |
| 2015 | PEDIATRICS | SCIE | Q2 | — | 32/120 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 141/255 |
| 2015 | PSYCHIATRY | SCIE | Q3 | — | 73/142 |
| 2014 | PEDIATRICS | SCIE | Q1 | — | 15/120 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 88/255 |
| 2014 | PSYCHIATRY | SCIE | Q2 | — | 51/140 |
| 2013 | PEDIATRICS | SCIE | Q1 | — | 11/118 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/256 |
| 2013 | PSYCHIATRY | SCIE | Q2 | — | 47/136 |
| 2012 | PEDIATRICS | SCIE | Q1 | — | 18/122 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 90/261 |
| 2012 | PSYCHIATRY | SCIE | Q2 | — | 53/135 |
| 2011 | PEDIATRICS | SCIE | Q1 | — | 15/115 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 87/261 |
| 2011 | PSYCHIATRY | SCIE | Q2 | — | 45/130 |
| 2010 | PEDIATRICS | SCIE | Q1 | — | 19/109 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 113/252 |
| 2010 | PSYCHIATRY | SCIE | Q2 | — | 53/128 |
| 2009 | PEDIATRICS | SCIE | Q1 | — | 15/94 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 101/237 |
| 2009 | PSYCHIATRY | SCIE | Q2 | — | 51/117 |
| 2008 | PEDIATRICS | SCIE | Q1 | — | 14/86 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 83/219 |
| 2008 | PSYCHIATRY | SCIE | Q2 | — | 42/101 |
| 2007 | PEDIATRICS | SCIE | Q1 | — | 5/78 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 56/205 |
| 2007 | PSYCHIATRY | SCIE | Q2 | — | 32/94 |
| 2006 | PEDIATRICS | SCIE | Q1 | — | 10/74 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/199 |
| 2006 | PSYCHIATRY | SCIE | Q2 | — | 40/94 |
| 2005 | PEDIATRICS | SCIE | Q1 | — | 8/73 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 69/193 |
| 2005 | PSYCHIATRY | SCIE | Q2 | — | 41/94 |
| 2004 | PEDIATRICS | SCIE | Q1 | — | 8/70 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 56/187 |
| 2004 | PSYCHIATRY | SCIE | Q2 | — | 30/90 |
| 2003 | PEDIATRICS | SCIE | Q1 | — | 6/68 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 52/185 |
| 2003 | PSYCHIATRY | SCIE | Q2 | — | 31/87 |
| 2002 | PEDIATRICS | SCIE | Q1 | — | 5/68 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 47/188 |
| 2002 | PSYCHIATRY | SCIE | Q2 | — | 28/88 |
| 2001 | PEDIATRICS | SCIE | Q1 | — | 12/69 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 64/186 |
| 2001 | PSYCHIATRY | SCIE | Q2 | — | 40/81 |
| 2000 | PEDIATRICS | SCIE | Q1 | — | 6/71 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 55/181 |
| 2000 | PSYCHIATRY | SCIE | Q2 | — | 28/82 |
| 1999 | PEDIATRICS | SCIE | Q1 | — | 6/72 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 41/175 |
| 1999 | PSYCHIATRY | SCIE | Q2 | — | 23/80 |
| 1998 | PEDIATRICS | SCIE | Q1 | — | 8/71 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 57/178 |
| 1998 | PSYCHIATRY | SCIE | Q2 | — | 23/77 |
| 1997 | PEDIATRICS | SCIE | Q1 | — | 6/66 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 37/157 |
| 1997 | PSYCHIATRY | SCIE | Q2 | — | 19/67 |